Active (not recruiting)
Phase 1
2025-525025-12-00
A trial comparing how the body absorbs and gets rid of petadeferitrin taken as two different forms in healthy people
Phase 1 – testing safety in a small group of people
Conditions:
Iron overload from thalassemia
transfusion-dependent myelodysplastic syndromea and haemolysis
Sponsor: Pharmacosmos A/S
trial.available_in:
БГ